CHOLESTERINUM PLEX (Seroyal USA)


Welcome to the PulseAid listing for the CHOLESTERINUM PLEX drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Cholesterinum, Cholesterinum, Hepatinum, Pulminum
SUBSTANCE NAME: CHOLESTEROL; ORYCTOLAGUS CUNICULUS LIVER; ORYCTOLAGUS CUNICULUS LUNG
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-08-16
END MARKETING DATE: 0000-00-00


CHOLESTERINUM PLEX HUMAN OTC DRUG Details:

Item DescriptionCHOLESTERINUM PLEX from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 9; 7; 7([hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL)
START MARKETING DATE: 2017-08-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1207_56e10d0b-1860-351a-e054-00144ff8d46c
PRODUCT NDC: 62106-1207
APPLICATION NUMBER:

Other CHOLESTEROL; ORYCTOLAGUS CUNICULUS LIVER; ORYCTOLAGUS CUNICULUS LUNG Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USACHOLESTERINUM PLEX